This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
Page 2 of 150

Pickens Primes Pump for a Mighty Wind

By Melissa Davis

The legendary oilman says it's time to break our addiction on fuel oil and explore alternative energy sources.

01:13PM 10/29/08

Zimmer Shares Slump on Forecast

By Melissa Davis

The device maker reels in its full-year forecast.

01:58PM 10/23/08

Wellpoint Hit by Financial Meltdown

By Melissa Davis

The health insurer's earnings were affected by bad investments in the financial industry.

01:30PM 10/22/08

Longs Shareholders Cinch CVS Caremark Deal

By Melissa Davis

The deal was completed Mondayl when Longs shareholders agreed to accept it.

01:12PM 10/20/08

Stryker Just Shy of Estimates

By Melissa Davis

The orthopedic device maker reported strong gains in revenue and profits for the quarter.

05:50PM 10/16/08

UnitedHealth's Profits Fall on Higher Costs

By Melissa Davis

The health insurer struggled with rising medical costs and investment losses during the quarter.

01:19PM 10/16/08

Walgreen's CEO Retires

By Melissa Davis

Jeffrey Rein retires two days after Walgreens made an unsuccessful attempt to take over Longs Drug Stores.

01:36PM 10/10/08

Longs' Options Limited After Walgreen's Exit

By Melissa Davis

Longs Drug Stores finds itself looking again at CVC-Caremark's offer.

05:33PM 10/09/08

Arthrocare Gets No Medicare Love

By Melissa Davis

A ruling by regulators may put sales of the company's spinal device in jeopardy.

12:13PM 10/02/08

Walgreen Wades into Antitrust Waters

By Melissa Davis

The company sees Hawaii as a key market.

04:56PM 09/30/08

Page 2 of 150

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs